Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Cash from Financing Activities (2016 - 2025)

Skinvisible (SKVI) has disclosed Cash from Financing Activities for 15 consecutive years, with $34780.0 as the latest value for Q1 2025.

  • Quarterly Cash from Financing Activities rose 78.36% to $34780.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $34780.0 through Dec 2025, down 60.7% year-over-year, with the annual reading at $34780.0 for FY2025, 60.7% down from the prior year.
  • Cash from Financing Activities hit $34780.0 in Q1 2025 for Skinvisible, up from $26636.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $36200.0 in Q2 2024 to a low of -$137000.0 in Q4 2021.
  • Historically, Cash from Financing Activities has averaged -$19632.0 across 4 years, with a median of $5082.0 in 2023.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 18400.0% in 2021 and later surged 565.9% in 2024.
  • Year by year, Cash from Financing Activities stood at -$137000.0 in 2021, then soared by 102.92% to $4000.0 in 2023, then soared by 565.9% to $26636.0 in 2024, then surged by 30.58% to $34780.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for SKVI at $34780.0 in Q1 2025, $26636.0 in Q4 2024, and $6164.0 in Q3 2024.